Anti-allergic actions of a Chinese patent medicine, huoxiangzhengqi oral liquid, in RBL-2H3 cells and in mice

CONCLUSIONS: HXZQ-OL attenuated the activation of mast cell and PCA. Therefore, HXZQ-OL might be used as an alternative treatment for allergic diseases.PMID:34078224 | DOI:10.1080/13880209.2021.1928242

Source: Pharmaceutical Biology - June 3, 2021 Category: Drugs & Pharmacology Authors: Jianbin Sun Sixing Huang Yao Qin Ping Zhang Ziwei Li Li Zhang Xin Wang Ruijun Wu Shaorong Qin Jiayong Huo Kunquan Xiao Weizao Luo Source Type: research